Thrivent Financial for Lutherans’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.52M | Buy |
45,576
+1,800
| +4% | +$99.5K | 0.01% | 1198 |
|
|
2025
Q1 | $2.12M | Sell |
43,776
-2,290
| -5% | -$111K | ﹤0.01% | 1260 |
|
|
2024
Q4 | $1.78M | Sell |
46,066
-191
| -0.4% | -$7.37K | ﹤0.01% | 1517 |
|
|
2024
Q3 | $2.08M | Buy |
+46,257
| New | +$2.08M | ﹤0.01% | 1410 |
|
|
2023
Q3 | – | Sell |
-73,381
| Closed | -$2.03M | – | 2484 |
|
|
2023
Q2 | $2.03M | Sell |
73,381
-27,612
| -27% | -$762K | ﹤0.01% | 1325 |
|
|
2023
Q1 | $2.32M | Hold |
100,993
| – | – | 0.01% | 1202 |
|
|
2022
Q4 | $1.1M | Hold |
100,993
| – | – | ﹤0.01% | 1667 |
|
|
2022
Q3 | $852K | Buy |
+100,993
| New | +$852K | ﹤0.01% | 1784 |
|